1. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D, et al. A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transplant. 2006;12:1049–61.
2. Abdallah A, Salman AA, Sholkamy AA, Salman MA, Omar MG, Youssef A, et al. Study of factors affecting small for size syndrome post-adult living donor liver transplantation. Asian J Surg. 2021;44:452–8.
3. Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. New Engl J Med. 1990;322:1505–7.
4. Raia S, Nery J, Mies S. Liver transplantation from live donors. Lancet. 1989;334:497.
5. Yoshizumi T, Itoh S, Shimokawa M, Inokuchi S, Harada N, Takeishi K, et al. Simultaneous splenectomy improves outcomes after adult living donor liver transplantation. J Hepatol. 2021;74:372–9.
6. Yoshizumi T, Taketomi A, Soejima Y, Ikegami T, Uchiyama H, Kayashima H, et al. The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transplant Int. 2008;21:833–42.
7. Soejima Y, Shirabe K, Taketomi A, Yoshizumi T, Uchiyama H, Ikegami T, et al. Left lobe living donor liver transplantation in adults. Am J Transplant. 2012;12:1877–85.
8. Yoshizumi T, Ikegami T, Bekki Y, Ninomiya M, Uchiyama H, Iguchi T, et al. Re-evaluation of the predictive score for 6- month graft survival in living donor liver transplantation in the modern era. Liver Transplant. 2014;20:323–32.
9. Chu MJJ, Dare AJ, Phillips ARJ, Bartlett ASJR. Donor hepatic steatosis and outcome after liver transplantation: a systematic review. J Gastrointest Surg. 2015;19:1713–24.
10. Segev DL, Kucirka LM, Nguyen GC, Cameron AM, Locke JE, Simpkins CE, et al. Effect modification in liver allografts with prolonged cold ischemic time. Am J Transplant. 2008;8: 658–66.
11. Durand F, Levitsky J, Cauchy F, Gilgenkrantz H, Soubrane O, Francoz C. Age and liver transplantation. J Hepatol. 2018;70:745–58.
12. Hidaka M, Eguchi S, Takatsuki M, Soyama A, Ono S, Adachi T, et al. The Kupffer cell number affects the outcome of living donor liver transplantation from elderly donors. Transplant Direct. 2016;2:e94.
13. López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153:1194–217.
14. Toshima T, Shirabe K, Fukuhara T, Ikegami T, Yoshizumi T, Soejima Y, et al. Suppression of autophagy during liver regeneration impairs energy charge and hepatocyte senescence in mice. Hepatology. 2014;60:290–300.
15. Schaum N, Lehallier B, Hahn O, Pálovics R, Hosseinzadeh S, Lee SE, et al. Ageing hallmarks exhibit organ-specific temporal signatures. Nature. 2020;583:596–602.
16. Kato Y, Griesemer AD, Wu A, Sondermeijer HP, Weiner JI, Duran-Struuck R, et al. Novel H-shunt venovenous bypass for liver transplantation in cynomolgus macaques. Comp Med. 2017;67:436–41.
17. Sogawa H, Boskovic S, Nadazdin O, Abrahamian G, Colvin RB, Sachs DH, et al. Limited efficacy and unacceptable toxicity of cyclophosphamide for the induction of mixed chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation. 2008;86:615–9.
18. Vons C, Beaudoin S, Helmy N, Dagher I, Weber A, Franco D. First description of the surgical anatomy of the cynomolgus monkey liver. Am J Primatol. 2009;71:400–8.
19. Lane MA. Nonhuman primate models in biogerontology. Exp Gerontol. 2000;35:533–41.
20. Didier ES, MacLean AG, Mohan M, Didier PJ, Lackner AA, Kuroda MJ. Contributions of nonhuman primates to research on aging. Vet Pathol. 2016;53:277–90.
21. Bronikowski AM, Altmann J, Brockman DK, Cords M, Fedigan LM, Pusey A, et al. Aging in the natural world: comparative data reveal similar mortality patterns across primates. Science. 2011;331:1325–8.
22. Niu Y, Shen B, Cui Y, Chen Y, Wang J, Wang L, et al. Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos. Cell. 2014;156:836–43.
23. Carlson CS, Loeser RF, Jayo MJ, Weaver DS, Adams MR, Jerome CP. Osteoarthritis in cynomolgus macaques: a primate model of naturally occurring disease. J Orthopaed Res. 1994;12:331–9.
24. Soejima Y, Shimada M, Suehiro T, Hiroshige S, Ninomiya M, Shiotani S, et al. Outcome analysis in adult-to-adult living donor liver transplantation using the left lobe. Liver Transplant. 2003;9:581–6.
25. Coppé J-P, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6:e301.
26. Zhu C, Ikemoto T, Utsunomiya T, Yamada S, Morine Y, Imura S, et al. Senescence-related genes possibly responsible for poor liver regeneration after hepatectomy in elderly patients. J Gastroen Hepatol. 2014;29:1102–8.
27. Scheuermann U, Seyferth ER, Abraham N, Kesseli SJ, Halpern SE, Zhu M, et al. Sirtuin-1 expression and activity is diminished in aged liver grafts. Sci Rep-uk. 2020;10:11860.
28. Schmucker DL. Age-related changes in liver structure and function: implications for disease? Exp Gerontol. 2005;40:650–9.
29. Prystupa A, Boguszewska-Czubara A, Bojarska-Junak A, Toruń-¬Jurkowska A, Roliński J, Załuska W. Activity of MMP-¬2, MMP-8 and MMP-9 in serum as a marker of progression of alcoholic liver disease in people from Lublin Region, eastern Poland. Ann Agr Env Med. 2015;22:325–8.
30. Shoji H, Yoshio S, Mano Y, Kumagai E, Sugiyama M, Korenaga M, et al. Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Sci Rep-uk. 2016;6:28814.
31. Kubota T, Hata K, Sozu T, Ueda Y, Hirao H, Okamura Y, et al. Impact of donor age on recipient survival in adult-to-adult livingdonor liver transplantation. Ann Surg. 2018;267:1126–33.
32. Slawik M, Vidal-Puig AJ. Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev. 2006;5:144–64.
33. Timchenko NA. Aging and liver regeneration. Trends Endocrinol Metabolism. 2009;20:171–6.
34. Tabula Muris Consortium. A single-cell transcriptomic atlas characterizes ageing tissues in the mouse. Nature. 2020;583: 590–5.
35. Šeda O, Cahová M, Míková I, Šedová L, Daňková H, Heczková M, et al. Hepatic gene expression profiles differentiate steatotic and non-steatotic grafts in liver transplant recipients. Front Endocrinol. 2019;10:270.
36. Ryaboshapkina M, Hammar M. Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis. Sci Rep-uk. 2017;7:12361.
37. Baiocchini A, Montaldo C, Conigliaro A, Grimaldi A, Correani V, Mura F, et al. Extracellular matrix molecular remodeling in human liver fibrosis evolution. Plos One. 2016;11:e0151736.
38. Gao S, Gang J, Yu M, Xin G, Tan H. Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer. BMC Cancer. 2021;21:791.
39. Sheikh A, Takatori A, Hossain MS, Hasan MK, Tagawa M, Nagase H, et al. Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway. Cancer Sci. 2016;107:1223–32.
40. Tanemura A, Mizuno S, Wada H, Yamada T, Nobori T, Isaji S. Donor age affects liver regeneration during early period in the graft liver and late period in the remnant liver after living donor liver transplantation. World J Surg. 2012;36:1102–11.
41. Goldaracena N, Sapisochin G, Spetzler V, Echeverri J, Kaths M, Cattral MS, et al. Live donor liver transplantation with older (≥50years) versus younger (<50years) donors. Ann Surg. 2016;263:979–85.
42. Kim SH, Lee EC, Shim JR, Park SJ. Right lobe living donors ages 55years old and older in liver transplantation. Liver Transplant. 2017;23:1305–11.
43. Almeida A, Zhu XX, Vogt N, Tyagi R, Muleris M, Dutrillaux A-M, et al. GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas. Oncogene. 1998;16:2997–3002.
44. Kuyvenhoven J, Molenaar Q, Verspaget H, Veldman M, Palareti G, Legnani C, et al. Plasma MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 during human orthotopic liver transplantation. Thromb Haemost. 2004;91:506–13.
45. Kato H, Kuriyama N, Duarte S, Clavien P-A, Busuttil RW, Coito AJ. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury. J Hepatol. 2014;60:1032–9.
46. Piccinino F, Sagnelli E, Pasquale G, Giusti G, Battocchia A, Bernardi M, et al. Complications following percutaneous liver biopsy: a multicentre retrospective study on 68 276 biopsies. J Hepatol. 1986;2:165–73.
47. Yousefzadeh MJ, Flores RR, Zhu Y, Schmiechen ZC, Brooks RW, Trussoni CE, et al. An aged immune system drives senescence and ageing of solid organs. Nature. 2021;594:100–5.
48. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–70.
49. Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology. 1995;21:1317–21.
50. Yoshizumi T, Ikegami T, Kimura K, Uchiyama H, Ikeda T, Shirabe K, et al. Selection of a right posterior sector graft for living donor liver transplantation. Liver Transplant. 2014;20:1089–96.
論文の公開元へ
